GSK PLC SP. ADR/2 NEW (GS70) — Financial Flexibility Index
GSK PLC SP. ADR/2 NEW (GS70) has a Financial Flexibility Index of 0.08x as of June 2026. Free cash flow of €3.34 Billion (operating CF €2.69 Billion minus capex €653.00 Million) represents 0% of total liabilities (€44.56 Billion). Check GSK PLC SP. ADR/2 NEW total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GSK PLC SP. ADR/2 NEW Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for GSK PLC SP. ADR/2 NEW across 5 annual periods. For the full cash flow conversion analysis, see GSK PLC SP. ADR/2 NEW cash conversion from operations.
Annual Financial Flexibility Index for GSK PLC SP. ADR/2 NEW (2021–2025)
Year-by-year free cash flow to debt coverage for GSK PLC SP. ADR/2 NEW. Explore GS70 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | €10.73 Billion | €7.74 Billion | €45.16 Billion | ▲ +15.5% |
| 2024 | 0.21x | €9.54 Billion | €6.55 Billion | €46.38 Billion | ▲ +4.3% |
| 2023 | 0.20x | €9.11 Billion | €6.77 Billion | €46.21 Billion | ▲ +2.2% |
| 2022 | 0.19x | €9.66 Billion | €7.40 Billion | €50.05 Billion | ▲ +5.1% |
| 2021 | 0.18x | €10.61 Billion | €7.95 Billion | €57.76 Billion | — |